OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
4920$1163.0058

Nippon Shikizai Inc

Personal ProductsVerified

Nippon Shikizai operates with a capital structure that is highly leveraged, as evidenced by a debt-to-equity ratio of 2.33, which is significantly higher than the median for the Personal Products industry. The company's liquidity position is constrained, with a current ratio of 0.94 and negative net cash after subtracting total debt. The price-to-book ratio of 0.56 and price-to-tangible-book ratio of 0.56 suggest that the company's market value is trading below its book value, indicating potential undervaluation or asset impairment concerns. Profitability metrics for Nippon Shikizai are modest. The company's return on equity (ROE) of 7.9% and return on assets (ROA) of 1.91% are below the industry median for ROE and ROA in the Personal Products sector. The operating margin, calculated as operating income of ¥17.3 billion on revenue of ¥16.64 billion, is 1.04%, which is significantly lower than the industry median for operating margins. This suggests that the company is underperforming in terms of operational efficiency and cost control. Nippon Shikizai's revenue is concentrated in its core cosmetics and medical products segments, with no disclosed geographic diversification in the input data. The company's exposure to Japan is likely high, given its domestic operations and lack of international revenue breakdown. This concentration increases vulnerability to domestic economic shifts and regulatory changes. The company's growth trajectory is weak. Revenue in the latest period was ¥16.64 billion, with no disclosed year-over-year growth rate. The outlook for the current fiscal year and the next fiscal year is not provided in the input data, but the low ROE and ROA suggest limited capacity for organic growth. The company's capital expenditures were negative at ¥754.27 million, indicating asset disposals or reduced investment in growth initiatives. Risk factors for Nippon Shikizai include its high leverage and constrained liquidity. The company's debt-to-equity ratio of 2.33 and negative net cash position increase financial risk. The risk assessment indicates a medium liquidity risk and low dilution risk, but the potential for dilution remains if the company issues additional shares to service debt or fund operations. The company's free cash flow of ¥474.87 million is insufficient to cover its long-term debt of ¥9.88 billion, suggesting reliance on external financing. Recent events and disclosures for Nippon Shikizai are limited in the input data. The company's latest actual EPS was 162.00 JPY, and its actual revenue was ¥16.64 billion, aligning with analyst estimates. No recent filings or transcripts are provided that would indicate strategic shifts or operational changes.

30-day price · 4920(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyNippon Shikizai Inc
Ticker4920.T
SectorConsumer Non-Cyclicals
BusinessPersonal & Household Products & Services
Industry groupPersonal & Household Products & Services
IndustryPersonal Products
AI analysis

Business. Nippon Shikizai, Inc. is a Japan-based company primarily engaged in the research, development, and manufacture of cosmetics and medical products, including foundations, UV creams, skin lotions, athlete's foot remedies, and medical toothpastes.

Classification. Nippon Shikizai is classified under the Consumer Non-Cyclicals economic sector, Personal & Household Products & Services business sector, and Personal Products industry with a confidence level of 0.92.

Nippon Shikizai operates with a capital structure that is highly leveraged, as evidenced by a debt-to-equity ratio of 2.33, which is significantly higher than the median for the Personal Products industry. The company's liquidity position is constrained, with a current ratio of 0.94 and negative net cash after subtracting total debt. The price-to-book ratio of 0.56 and price-to-tangible-book ratio of 0.56 suggest that the company's market value is trading below its book value, indicating potential undervaluation or asset impairment concerns. Profitability metrics for Nippon Shikizai are modest. The company's return on equity (ROE) of 7.9% and return on assets (ROA) of 1.91% are below the industry median for ROE and ROA in the Personal Products sector. The operating margin, calculated as operating income of ¥17.3 billion on revenue of ¥16.64 billion, is 1.04%, which is significantly lower than the industry median for operating margins. This suggests that the company is underperforming in terms of operational efficiency and cost control. Nippon Shikizai's revenue is concentrated in its core cosmetics and medical products segments, with no disclosed geographic diversification in the input data. The company's exposure to Japan is likely high, given its domestic operations and lack of international revenue breakdown. This concentration increases vulnerability to domestic economic shifts and regulatory changes. The company's growth trajectory is weak. Revenue in the latest period was ¥16.64 billion, with no disclosed year-over-year growth rate. The outlook for the current fiscal year and the next fiscal year is not provided in the input data, but the low ROE and ROA suggest limited capacity for organic growth. The company's capital expenditures were negative at ¥754.27 million, indicating asset disposals or reduced investment in growth initiatives. Risk factors for Nippon Shikizai include its high leverage and constrained liquidity. The company's debt-to-equity ratio of 2.33 and negative net cash position increase financial risk. The risk assessment indicates a medium liquidity risk and low dilution risk, but the potential for dilution remains if the company issues additional shares to service debt or fund operations. The company's free cash flow of ¥474.87 million is insufficient to cover its long-term debt of ¥9.88 billion, suggesting reliance on external financing. Recent events and disclosures for Nippon Shikizai are limited in the input data. The company's latest actual EPS was 162.00 JPY, and its actual revenue was ¥16.64 billion, aligning with analyst estimates. No recent filings or transcripts are provided that would indicate strategic shifts or operational changes.
Key takeaways
  • Nippon Shikizai is highly leveraged with a debt-to-equity ratio of 2.33, indicating significant financial risk.
  • The company's profitability metrics, including ROE of 7.9% and ROA of 1.91%, are below industry medians, suggesting operational inefficiencies.
  • Nippon Shikizai's liquidity position is constrained, with a current ratio of 0.94 and negative net cash after subtracting total debt.
  • The company's revenue is concentrated in its core segments with no disclosed geographic diversification, increasing vulnerability to domestic economic shifts.
  • Growth prospects are limited, with no disclosed year-over-year revenue growth and negative capital expenditures indicating reduced investment in growth initiatives.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyJPY
Revenue$16.64B
Gross profit$2.20B
Operating income$173.0M
Net income$335.4M
R&D
SG&A
D&A
SBC
Operating cash flow$140.2M
CapEx-$754.3M
Free cash flow$474.9M
Total assets$17.57B
Total liabilities$13.32B
Total equity$4.24B
Cash & equivalents$1.09B
Long-term debt$9.88B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price$1163.00
Market cap$2.36B
Enterprise value$11.15B
P/E7.0
Reported non-GAAP P/E
EV/Revenue0.7
EV/Op income64.5
EV/OCF79.5
P/B0.6
P/Tangible book0.6
Tangible book$4.24B
Net cash-$8.79B
Current ratio0.9
Debt/Equity2.3
ROA1.9%
ROE7.9%
Cash conversion42.0%
CapEx/Revenue-4.5%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Personal Products · cohort 225 companies
Metric4920Activity
Op margin1.0%16.2% medp25 16.2% · p75 16.2%bottom quartile
Net margin2.0%10.5% medp25 10.5% · p75 10.5%bottom quartile
Gross margin13.2%60.1% medp25 60.1% · p75 60.1%bottom quartile
R&D / revenue1.8% medp25 1.8% · p75 1.8%
CapEx / revenue-4.5%-2.3% medp25 -4.4% · p75 -1.1%bottom quartile
Debt / equity233.0%12724.1% medp25 12724.1% · p75 12724.1%bottom quartile
Observations
IR observations
Last actual EPS162.00 JPY
Last actual revenue16,643,030,000 JPY
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-04 18:51 UTC#9b0710cf
Market quoteclose JPY 1163.00 · shares 0.00B diluted
no public URL
2026-05-04 18:51 UTC#23a6c27e
Source: analysis-pipeline (hybrid)Generated: 2026-05-04 18:53 UTCJob: 6cad4875